In line with the approval and funding of the company's 2030 strategic plan announced last November, Amyris is completing construction of the fourth independent precision fermentation line at the Barra ...

Eli Lilly and Company today announced that data from studies of orforglipron, insulin efsitora alfa, tirzepatide (Zepbound and Mounjaro), retatrutide, eloralintide and bimagrumab will be presented at ...

One of the longstanding challenges in chemical biology has been finding ways to directly observe biological processes at work ...

Learn how CD34+ stem cells may help heart attack patients recover. A look at cutting-edge cell therapies and what's coming ...

Aldeyra Therapeutics, Inc. (Aldeyra), a biotechnology company devoted to discovering and developing innovative therapies designed to treat immune-mediated and metabolic diseases, today announced that ...